Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Equity (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of Return on Equity data on record, last reported at 0.54% in Q4 2025.

  • For Q4 2025, Return on Equity rose 56.0% year-over-year to 0.54%; the TTM value through Dec 2025 reached 0.54%, up 56.0%, while the annual FY2025 figure was 0.78%, 80.0% up from the prior year.
  • Return on Equity reached 0.54% in Q4 2025 per TGTX's latest filing, down from 0.95% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.15% in Q3 2023 and bottomed at 2.11% in Q3 2022.
  • Average Return on Equity over 5 years is 0.4%, with a median of 0.35% recorded in 2023.
  • Peak YoY movement for Return on Equity: soared 949bps in 2021, then tumbled -122bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 1.28% in 2021, then surged by 44bps to 0.72% in 2022, then soared by 112bps to 0.08% in 2023, then tumbled by -118bps to 0.01% in 2024, then soared by 3744bps to 0.54% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.54% in Q4 2025, 0.95% in Q3 2025, and 0.13% in Q2 2025.